glp-1 for binge eating Does Help with Eating? UK Evidence and Guidance GLP-1s may reduce binge eating
Description
The OASIS 4 trial demonstrated 13.6% mean body weight loss at 64 weeks with oral semaglutide 25 mgcomparable to injectable formulations
The medication is administered through a once-weekly injection in the skin of the abdomen, thighs, or upper arm
Lean protein sources and easily digestible foods are prioritized to alleviate GI discomfort, while soluble fiber options are included for GI health
Protein, activity, and sleep drive body-composition outcomes independent of the compound
Meal planning on tirzepatide follows the same protein-priority principles, but the appetite suppression tends to be even more pronounced than with semaglutide alone
Comorbidities Increase Likelihood of GLP-1 Use Researchers reviewed patients diagnosed with HS between October 2015 and December 2023
